BSEM (BioStem Technologies) Total Assets: $62.4 Mil (As of Sep. 2025)


BSEM BioStem Technologies Inc BSEM
49 GF Score
Price $3.30
GF Value $139.96
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is BioStem Technologies Total Assets?

BioStem Technologies BSEM -5.17% 49 Total Assets is $62.4 Mil as of Sep. 2025. GuruFocus rates BSEM with a GF Score™ of 49/100 and a GF Value™ of $139.96 (Possible Value Trap). The stock has 3 warning signs investors should review.

BioStem Technologies's Total Assets for the quarter that ended in Sep. 2025 was $62.4 Mil.

During the past 12 months, BioStem Technologies's average Total Assets Growth Rate was 517.70% per year. During the past 3 years, the average Total Assets Growth Rate was 269.40% per year. During the past 5 years, the average Total Assets Growth Rate was 96.30% per year. During the past 10 years, the average Total Assets Growth Rate was 37.40% per year.

During the past 13 years, BioStem Technologies's highest 3-Year average Total Assets Growth Rate was 269.40%. The lowest was -60.90%. And the median was 5.30%.

Total Assets is connected with ROA %. BioStem Technologies's annualized ROA % for the quarter that ended in Sep. 2025 was 3.00%. Total Assets is also linked to Revenue through Asset Turnover. BioStem Technologies's Asset Turnover for the quarter that ended in Sep. 2025 was 0.10.

BioStem Technologies  (OTCPK:BSEM) Total Assets Explanation

Total Assets is connected with ROA %.

BioStem Technologies's annualized ROA % for the quarter that ended in Sep. 2025 is

ROA %=Net Income (Q: Sep. 2025 )/( (Total Assets (Q: Dec. 2024 )+Total Assets (Q: Sep. 2025 ))/ count )
=3.044/( (140.376+62.393)/ 2 )
=3.044/101.3845
=3.00 %

Note: The Net Income data used here is four times the quarterly (Sep. 2025) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

BioStem Technologies's Asset Turnover for the quarter that ended in Sep. 2025 is

Asset Turnover
=Revenue (Q: Sep. 2025 )/( (Total Assets (Q: Dec. 2024 )+Total Assets (Q: Sep. 2025 ))/ count )
=10.473/( (140.376+62.393)/ 2 )
=10.473/101.3845
=0.10

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

BioStem Technologies Total Assets Related Terms

BioStem Technologies Total Assets Historical Data

* Premium members only.

The historical data trend for BioStem Technologies's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BioStem Technologies Total Assets Chart

BioStem Technologies Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Total Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.67 2.67 3.47 14.56 140.38

BioStem Technologies Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Sep21 Dec21 Mar22 Sep22 Dec22 Mar23 Sep23 Dec23 Sep24 Dec24 Sep25
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.81 14.56 104.20 140.38 62.39
BSEM
49GF Score
BioStem Technologies Inc BSEM
Total Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

BioStem Technologies Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

BioStem Technologies's Total Assets for the fiscal year that ended in Dec. 2024 is calculated as

Total Assets=Total Equity (A: Dec. 2024 )+Total Liabilities (A: Dec. 2024 )
=40.876+99.5
=140.4

BioStem Technologies's Total Assets for the quarter that ended in Sep. 2025 is calculated as

Total Assets=Total Equity (Q: Sep. 2025 )+Total Liabilities (Q: Sep. 2025 )
=50.016+12.376
=62.4

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Assets →
What does a Total Assets of $62.4 Mil mean?
BioStem Technologies (BSEM) has a Total Assets of $62.4 Mil as of Sep. 2025. The total amount of assets as recorded on a company's balance sheet. View historical data on BioStem Technologies and its competitors.
Is BioStem Technologies' Total Assets too high?
BioStem Technologies' current Total Assets is $62.4 Mil. Overall, BioStem Technologies has a GF Score™ of 49/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does BioStem Technologies' Total Assets compare to XLO and TCRX?
BioStem Technologies' Total Assets of $62.4 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Assets for a Biotechnology company?
A good Total Assets depends on the Biotechnology industry context. However, Total Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Assets mean?
A high Total Assets can signal that a stock is expensive relative to its fundamentals. The total amount of assets as recorded on a company's balance sheet. View historical data on BioStem Technologies and its competitors. BioStem Technologies's current Total Assets is $62.4 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BioStem Technologies stock overvalued right now?
Based on GuruFocus' analysis, BioStem Technologies (BSEM) is currently considered Possible Value Trap. The stock's GF Value™ is $139.96, compared to a current price of $3.30 — trading 97.6% below its estimated fair value. The current Total Assets is $62.4 Mil. BioStem Technologies' overall GF Score™ is 49/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Assets calculated?
Total Assets is calculated from a company's financial statements. For BioStem Technologies (BSEM), the current Total Assets is $62.4 Mil as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is BioStem Technologies (BSEM) Overvalued in 2026?

Based on GuruFocus' analysis, BioStem Technologies stock appears to be undervalued. The current stock price of $3.30 is trading 97.6% below its estimated GF Value™ of $139.96. GuruFocus considers BioStem Technologies to be Possible Value Trap.

Key valuation signals for BSEM:

  • Total Assets: $62.4 Mil
  • GF Value™: $139.96 vs. price of $3.30 (97.6% below fair value)
  • GF Score™: 49/100 with 3 warning signs

No single metric tells the full story. See the BSEM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

BioStem Technologies Business Description

Address 2836 Center Port Circle, Pompano Beach, FL, USA, 33064
BioStem Technologies Inc is a regenerative biotechnology company focused on harnessing elements of perinatal tissue and the body's innate biology to repair or reverse damage caused by a broad range of degenerative diseases. The company develops, manufactures, and sells tissue allografts for the wound care market with a focus on the treatment of diabetic, pressure, and venous ulcers. Utilizing its proprietary BioRetain processing method, it manufactures perinatal tissue allografts. The company offers a comprehensive portfolio of high-quality brands that are trademarked and include VENDAJE AC, AmnioWrap2, and Others. The company generates key revenue from VENDAJE AC.
49GF Score

Get the complete analysis for BSEM

Total Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$3.30
Price
$139.96
GF Value